Abstract
Objective: To determine whether certain rheumatic diseases will affect the fetal thymus diameter when compared to uncomplicated singleton pregnancies. Additionally, we created a reference chart for fetal thymus size in healthy singleton pregnancies from 19 to 37 weeks of gestation.
Methods: Sonographic fetal thymus size was retrospectively evaluated in 190 healthy pregnant women, and 84 pregnancies of mothers suffering from systemic lupus erythematosus, antiphospholipid syndrome (APS), or Sjögren’s syndrome between 19 and 37 weeks of gestation. These fetuses were matched one-to-one for gestational age with control fetuses. The thymic-thoracic ratio (TT-ratio) was defined as the quotient of the anteroposterior thymic and the intrathoracic mediastinal diameter.
Results: Rheumatic diseases often affect pregnancy outcome, especially in case of primary APS. The TT ratio of fetuses of mothers suffering from rheumatic disease was equal to controls (P=0.807).
Conclusions: Ours is the first study to assess the correlation of fetal thymus size in high-risk pregnancies with rheumatic diseases in comparison to controls. Women with rheumatic diseases deal with pregnancy complications more frequently than controls. Our data suggest that maternal rheumatic diseases do not affect the fetal thymus size.
References
[1] Ambrosi A, Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal auto-antibodies. Arthritis Res Ther. 2012;14:208.10.1186/ar3787Search in Google Scholar PubMed PubMed Central
[2] Bramham K, Soh MC, Nelson-Piercy C. Pregnancy and renal outcomes in lupus nephritis: an update and guide to management. Lupus. 2012;21:1271–83.10.1177/0961203312456893Search in Google Scholar PubMed
[3] Chaoui R, Heling K, Mielke G, Hofbeck M, Gembruch U. Quality standards of the DEGUM for performance of fetal echocardiography. Ultraschall Med. 2008;29:197–200.10.1055/s-2008-1027302Search in Google Scholar PubMed
[4] Chaoui R, Heling KS, Sarut Lopez A, Thiel G, Karl K. The thymic-thoracic ratio in fetal heart defects: a simple way to identify fetuses at high risk for microdeletion 22q11. Ultrasound Obstet Gynecol. 2011;37:397–403.10.1002/uog.8952Search in Google Scholar PubMed
[5] Cromi A, Ghezzi F, Raffaelli R, Bergamini V, Siesto G, Bolis P. Ultrasonographic measurement of thymus size in IUGR fetuses: a marker of the fetal immunoendocrine response to malnutrition. Ultrasound Obstet Gynecol. 2009;33:421–6.10.1002/uog.6320Search in Google Scholar PubMed
[6] De Leon-Luis J, Gámez F, Pintado P, Antolin E, Pérez R, Ortiz-Quintana L, et al. Sonographic measurements of the thymus in male and female fetuses. J Ultrasound Med. 2009;28:43–8.10.7863/jum.2009.28.1.43Search in Google Scholar PubMed
[7] De Leon-Luis J, Santolaya J, Gamez F, Pintado P, Perez R, Ortiz-Quintana L. Sonographic thymic measurements in Down syndrome fetuses. Prenat Diagn. 2011;31:841–5.10.1002/pd.2783Search in Google Scholar PubMed
[8] Felker RE, Cartier MS, Emerson DS, Brown DL. Ultrasound of the fetal thymus. J Ultrasound Med. 1989;8:669–73.10.7863/jum.1989.8.12.669Search in Google Scholar PubMed
[9] Gámez F, De Leon-Luis J, Pintado P, Pérez R, Robinson JN, Antolin E, et al. Fetal thymus size in uncomplicated twin and singleton pregnancies. Ultrasound Obstet Gynecol. 2010;36:302–7.10.1002/uog.7578Search in Google Scholar PubMed
[10] Georgiou PE, Politi EN, Katsimbri P, Sakka V, Drosos AA. Outcome of lupus pregnancy: a controlled study. Rheumatology. 2000;39:1014–9.10.1093/rheumatology/39.9.1014Search in Google Scholar PubMed
[11] Kwok LW, Tam LS, Zhu TY, Leung YY, Li EK. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematodes. Lupus. 2011;20:829–36.10.1177/0961203310397967Search in Google Scholar PubMed
[12] Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Andreu MR, et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology. 2006;45:332–8.10.1093/rheumatology/kei159Search in Google Scholar PubMed
[13] Mecacci F, Bianchi B, Pieralli A, Mangani B, Moretti A, Cioni R, et al. Pregnancy outcome in systemic lupus erythematodes complicated by anti-phospholipid antibodies. Rheumatology. 2009;48:246–9.10.1093/rheumatology/ken458Search in Google Scholar PubMed
[14] Mohamed N, Eviston DP, Quinton AE, Benzie RJ, Kirby AC, Peek MJ, et al. Smaller fetal thymuses in pre-eclampsia: a prospective cross-selectional study. Ultrasound Obstet Gynecol. 2011;37:410–5.10.1002/uog.8953Search in Google Scholar PubMed
[15] Musilova I, Hornychova H, Kostal M, Jacobsson B, Kacerovsky M. Ultrasound measurement of the transverse diameter of the fetal thymus in pregnancies complicated by the preterm prelabor rupture of membranes. J Clin Ultrasound. 2013;41:283–9.10.1002/jcu.22027Search in Google Scholar PubMed
[16] Olearo E, Oberto M, Oggè G, Botta G, Pace C, Gaglioti P, et al. Thymic volume in healthy, small for gestational age and growth restricted fetuses. Prenat Diagn. 2012;32:662–7.10.1002/pd.3883Search in Google Scholar PubMed
[17] Smyth A, Oliviera GHM, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systematic lupus erythematodes and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–8.10.2215/CJN.00240110Search in Google Scholar PubMed PubMed Central
[18] Yinon Y, Zalel Y, Weisz B, Mazaki-Tovi S, Sivan E, Schiff E, et al. Fetal thymus size as a predictor of chorioamnionitis in women with preterm premature rupture of membranes. Ultrasound Obstet Gynecol. 2007;29:638–43.10.1002/uog.4022Search in Google Scholar PubMed
[19] Zalel Y, Gamzu R, Mashiach S, Achiron R. The development of the fetal thymus: an in utero sonographic evaluation. Prenat Diagn. 2002;22:114–7.10.1002/pd.257Search in Google Scholar PubMed
The authors stated that there are no conflicts of interest regarding the publication of this article.
©2014 by De Gruyter
